Selective and efficient generation of functional Batf3-dependent CD1031 dendritic cells from mouse bone marrow

Blood

Volumn 124, Issue 20, 2014, Pages 3081-3091

  Mayer, Christian Thomas ^a   Ghorbani, Peyman ^a   Nandan, Amrita ^a   Dudek, Markus ^a   Arnold Schrauf, Catharina ^a   Hesse, Christina ^a   Berod, Luciana ^a   Stüve, Philipp ^a   Puttur, Franz ^a   Merad, Miriam ^b   Sparwasser, Tim ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BATF3 PROTEIN; CD103 ANTIGEN; CD135 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; DENDRITIC CELL VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; PROTEIN; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; ALPHA E INTEGRINS; ALPHA INTEGRIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; FLT3 LIGAND PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; REPRESSOR PROTEIN; SNFT PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL AGGREGATION; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; GENE ACTIVITY; GENE EXPRESSION; IMMUNE RESPONSE; IN VIVO STUDY; LYMPH NODE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; T LYMPHOCYTE; VACCINATION; ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; IMMUNOLOGY; PROCEDURES;

ANIMALS; ANTIGENS, CD; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNITY, CELLULAR; INTEGRIN ALPHA CHAINS; MEMBRANE PROTEINS; MICE; REPRESSOR PROTEINS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 3;

EID: 84911932242     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-12-545772     Document Type: Article

References (50)

1. Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunol Rev. 2010;234(1):45-54.
2. Mayer CT, Berod L, Sparwasser T. Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Front Immunol. 2012;3:183.
3. Ginhoux F, Liu K, Helft J, et al. The origin and development of nonlymphoid tissue CD1031 DCs. J Exp Med. 2009;206(13):3115-3130.
4. Contreras V, Urien C, Guiton R, et al. Existence of CD8a-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J Immunol. 2010;185(6):3313-3325.
5. Crozat K, Guiton R, Contreras V, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha1 dendritic cells. J Exp Med. 2010; 207(6):1283-1292.
6. Poulin LF, Salio M, Griessinger E, et al. Characterization of human DNGR-11 BDCA31 leukocytes as putative equivalents of mouse CD8alpha1 dendritic cells. J Exp Med. 2010; 207(6):1261-1271.
7. Satpathy AT, Wu X, Albring JC, Murphy KM. Re(de)fining the dendritic cell lineage. Nat Immunol. 2012;13(12):1145-1154.
8. Bedoui S, Whitney PG, Waithman J, et al. Cross-presentation of viral and self antigens by skin-derived CD1031 dendritic cells. Nat Immunol. 2009;10(5):488-495.
9. Henri S, Poulin LF, Tamoutounour S, et al. CD2071 CD1031 dermal dendritic cells crosspresent keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med. 2010;207(1):189-206, S181-186.
10. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31:563-604.
11. Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999; 223(1):77-92.
12. Naik SH, Proietto AI, Wilson NS, et al. Cutting edge: generation of splenic CD81 and CD8-dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol. 2005;174(11):6592-6597.
13. Edelson BT, Bradstreet TR, Kc W, et al. Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization. PLoS ONE. 2011; 6(10):e25660.
14. Sathe P, Pooley J, Vremec D, et al. The acquisition of antigen cross-presentation function by newly formed dendritic cells. J Immunol. 2011; 186(9):5184-5192.
15. Jackson JT, Hu Y, Liu R, et al. Id2 expression delineates differential checkpoints in the genetic program of CD8a1 and CD1031 dendritic cell lineages. EMBO J. 2011;30(13):2690-2704.
16. Hildner K, Edelson BT, Purtha WE, et al. Batf3 deficiency reveals a critical role for CD8alpha1 dendritic cells in cytotoxic T cell immunity. Science. 2008;322(5904):1097-1100.
17. MartIn-Fontecha A, Sebastiani S, Höpken UE, et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med. 2003;198(4): 615-621.
18. Dawicki W, Jawdat DW, Xu N, Marshall JS. Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol. 2010;184(4):2116-2123.
19. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007;7(1):19-30.
20. Diao J, Winter E, Chen W, Cantin C, Cattral MS. Characterization of distinct conventional and plasmacytoid dendritic cell-committed precursors in murine bone marrow. J Immunol. 2004;173(3): 1826-1833.
21. Bogunovic M, Ginhoux F, Helft J, et al. Origin of the lamina propria dendritic cell network. Immunity. 2009;31(3):513-525.
22. Greter M, Helft J, Chow A, et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity. 2012; 36(6):1031-1046.
23. Jakubzick C, Tacke F, Ginhoux F, et al. Blood monocyte subsets differentially give rise to CD1031 and CD103-pulmonary dendritic cell populations. J Immunol. 2008;180(5):3019-3027.
24. Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol. 2007;178(4):2000-2007.
25. Suzuki S, Honma K, Matsuyama T, et al. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha-dendritic cell development. Proc Natl Acad Sci USA. 2004;101(24): 8981-8986.
26. Merad M, Manz MG. Dendritic cell homeostasis. Blood. 2009;113(15):3418-3427.
27. Jakubzick C, Bogunovic M, Bonito AJ, Kuan EL, Merad M, Randolph GJ. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med. 2008;205(12):2839-2850.
28. Miller JC, Brown BD, Shay T, et al; Immunological Genome Consortium. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol. 2012;13(9):888-899.
29. Gautier EL, Shay T, Miller J, et al; Immunological Genome Consortium. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol. 2012;13(11): 1118-1128.
30. Jelinek I, Leonard JN, Price GE, et al. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol. 2011;186(4):2422-2429.
31. Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O'Keeffe M. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol. 2001;166(9): 5448-5455.
32. Naik SH. Generation of large numbers of pro-DCs and pre-DCs in vitro. Methods Mol Biol. 2010;595: 177-186.
33. Segura E, Wong J, Villadangos JA. Cutting edge: B2201CCR9-dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells. J Immunol. 2009;183(3):1514-1517.
34. Naik SH, Metcalf D, van Nieuwenhuijze A, et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol. 2006;7(6):663-671.
35. Poulin LF, Reyal Y, Uronen-Hansson H, et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood. 2012;119(25):6052-6062.
36. Schraml BU, van Blijswijk J, Zelenay S, et al. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell. 2013;154(4):843-858.
37. Helft J, Manicassamy B, Guermonprez P, et al. Cross-presenting CD1031 dendritic cells are protected from influenza virus infection. J Clin Invest. 2012;122(11):4037-4047.
38. del Rio ML, Rodriguez-Barbosa JI, Bölter J, et al. CX3CR11 c-kit1 bone marrow cells give rise to CD1031 and CD103-dendritic cells with distinct functional properties. J Immunol. 2008;181(9): 6178-6188.
39. Zhan Y, Carrington EM, van Nieuwenhuijze A, et al. GM-CSF increases cross-presentation and CD103 expression by mouse CD8+ spleen dendritic cells. Eur J Immunol. 2011;41(9): 2585-2595.
40. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006;6(4): 295-307.
41. Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 2012;12(4): 265-277.
42. Sparwasser T, Koch ES, Vabulas RM, et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol. 1998; 28(6):2045-2054.
43. Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, et al. A functionally specialized population of mucosal CD1031 DCs induces Foxp31 regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007; 204(8):1757-1764.
44. Yamazaki S, Dudziak D, Heidkamp GF, et al. CD81 CD2051 splenic dendritic cells are specialized to induce Foxp31 regulatory T cells. J Immunol. 2008;181(10):6923-6933.
45. Ohl L, Mohaupt M, Czeloth N, et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity. 2004;21(2):279-288.
46. Kingston D, Schmid MA, Onai N, Obata-Onai A, Baumjohann D, Manz MG. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood. 2009;114(4):835-843.
47. Proietto AI, Mittag D, Roberts AW, Sprigg N, Wu L. The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34(1) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin. Cell Mol Immunol. 2012;9(6):446-454.
48. Semmrich M, Plantinga M, Svensson-Frej M, et al. Directed antigen targeting in vivo identifies a role for CD1031 dendritic cells in both tolerogenic and immunogenic T-cell responses. Mucosal Immunol. 2012;5(2):150-160.
49. Suffia I, Reckling SK, Salay G, Belkaid Y. A role for CD103 in the retention of CD41CD251 Treg and control of Leishmania major infection. J Immunol. 2005;174(9):5444-5455.
50. Annacker O, Coombes JL, Malmstrom V, et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med. 2005;202(8):1051-1061.